/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%

ABUS — Arbutus Biopharma Corporation Common Stock

Nasdaq

Arbutus Biopharma Corporation Common Stock

Back to Screener
$4.56
-0.22(-4.60%)
O
4.77
H
4.78
L
4.51
V
16.62M
⏱️ End-of-day dataAs of Oct 1, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Arbutus Biopharma Corporation Common Stock Statistics

Total Valuation

Market Cap$960.81M
Enterprise Value$937.11M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding198.11M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio5.24
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio91.20
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings55.22
EV / Salesn/a
EV / EBITDA55.14
EV / EBIT55.22
EV / FCF-115.55

Financial Position

Current Ratio5.43
Quick Ration/a
Debt / Equity0.00
Debt / EBITDA0.00
Debt / FCF-0.00
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)158.16%
Return on Assets (ROA)61.23%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$893,132
Employee Count19
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change-0.65%
50-Day Moving Average$4.83
200-Day Moving Average$4.54
Relative Strength Index (RSI)18.89
Average Volume (20 Days)7,826,381

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income$16.91M
Pretax Income$16.97M
Net Income$16.97M
EBITDA$16.99M
EBIT$16.97M
Earnings Per Share$0.87

Balance Sheet

Cash & Cash Equivalents$23.71M
Total Debt$0
Net Cash$23.71M
Net Cash Per Share$0.12
Equity (Book Value)$10.73M
Book Value Per Share$0.05
Working Capital$22.60M

Cash Flow

Operating Cash Flow-$7.56M
Capital Expendituresn/a
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$8.11M
FCF Per Share$-0.04

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield19.08%
FCF Yield-0.84%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$13.05
Lynch Upside+186.18%
Graham Number$0.99
Graham Upside-78.29%

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a